Amyloid accelerator polyphosphate fits as the mystery density in α-synuclein fibrils
PLOS Biology · 2024
DOI: 10.1371/journal.pbio.3002650 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Biology, 2024. Verfasst von Philipp Huettemann und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular, Cellular and Developmental Biology, University of Michigan, Ann Arbor, Michigan, United States of America. Hauptthemen laut MEDLINE: Polyphosphates, alpha-Synuclein, Amyloid, Molecular Dynamics Simulation. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIH, HHMI.
Abstract (Originalsprache)
Aberrant aggregation of α-Synuclein is the pathological hallmark of a set of neurodegenerative diseases termed synucleinopathies. Recent advances in cryo-electron microscopy have led to the structural determination of the first synucleinopathy-derived α-Synuclein fibrils, which contain a non-proteinaceous, “mystery density” at the core of the protofilaments, hypothesized to be highly negatively charged. Guided by previous studies that demonstrated that polyphosphate (polyP), a universally conserved polyanion, significantly accelerates α-Synuclein fibril formation, we conducted blind docking and molecular dynamics simulation experiments to model the polyP binding site in α-Synuclein fibrils. Here, we demonstrate that our models uniformly place polyP into the lysine-rich pocket, which coordinates the mystery density in patient-derived fibrils. Subsequent in vitro studies and experiments in cells revealed that substitution of the 2 critical lysine residues K43 and K45 with alanine residues leads to a loss of all previously reported effects of polyP binding on α-Synuclein, including stimulation of fibril formation, change in filament conformation and stability as well as alleviation of cytotoxicity. In summary, our study demonstrates that polyP fits the unknown electron density present in in vivo α-Synuclein fibrils and suggests that polyP exerts its functions by neutralizing charge repulsion between neighboring lysine residues.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Molecular, Cellular and Developmental Biology, University of Michigan, Ann Arbor, Michigan, United States of America.
- Institute for Neurodegenerative Diseases, University of California San Francisco, California, United States of America.
- Department of Bioinformatics, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal, India.
- Department of Biochemistry, Microbiology, and Immunology, Wayne State University, Detroit, Michigan, United States of America.
- Howard Hughes Medical Institute, University of Michigan, Ann Arbor, Michigan, United States of America.
- Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor, Michigan, United States of America.
ORCID-Profile: Ursula Jakob
Förderung
- NIGMS NIH HHS
- NIH
- HHMI
Zitieren
APA
Huettemann, P., Mahadevan, P., Lempart, J., Tse, E., Dehury, B., Edwards, B. F. P., Southworth, D. R., Sahoo, B. R., & Jakob, U. (2024). Amyloid accelerator polyphosphate fits as the mystery density in α-synuclein fibrils. PLOS Biology. https://doi.org/10.1371/journal.pbio.3002650
Vancouver
Huettemann P, Mahadevan P, Lempart J, Tse E, Dehury B, Edwards BFP, et al. Amyloid accelerator polyphosphate fits as the mystery density in α-synuclein fibrils. PLOS Biology. 2024. doi:10.1371/journal.pbio.3002650
BibTeX
@article{Huettemann2024,
author = {Huettemann, Philipp and Mahadevan, Pavithra and Lempart, Justine and Tse, Eric and Dehury, Budheswar and Edwards, Brian F P and Southworth, Daniel R and Sahoo, Bikash R and Jakob, Ursula},
title = {Amyloid accelerator polyphosphate fits as the mystery density in α-synuclein fibrils},
journal = {PLOS Biology},
year = {2024},
doi = {10.1371/journal.pbio.3002650}
}
EUVIMED